The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

Challenging Cases of BC: What Should Be the Next Line of Therapy for a Woman With HR+ mBC Who Received 1L ET + CDK4/6i? Should You Extend ET Beyond 5 Yrs for T2N0 HR+ Grade II IDC?

320 views
February 28, 2021
Comments 0
Login to view comments. Click here to Login